These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 33086062)
1. Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma. Maitituoheti M; Keung EZ; Tang M; Yan L; Alam H; Han G; Singh AK; Raman AT; Terranova C; Sarkar S; Orouji E; Amin SB; Sharma S; Williams M; Samant NS; Dhamdhere M; Zheng N; Shah T; Shah A; Axelrad JB; Anvar NE; Lin YH; Jiang S; Chang EQ; Ingram DR; Wang WL; Lazar A; Lee MG; Muller F; Wang L; Ying H; Rai K Cell Rep; 2020 Oct; 33(3):108293. PubMed ID: 33086062 [TBL] [Abstract][Full Text] [Related]
2. Histone-methyltransferase KMT2D deficiency impairs the Fanconi anemia/BRCA pathway upon glycolytic inhibition in squamous cell carcinoma. Liu W; Cao H; Wang J; Elmusrati A; Han B; Chen W; Zhou P; Li X; Keysar S; Jimeno A; Wang CY Nat Commun; 2024 Aug; 15(1):6755. PubMed ID: 39117659 [TBL] [Abstract][Full Text] [Related]
3. KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer. Alam H; Tang M; Maitituoheti M; Dhar SS; Kumar M; Han CY; Ambati CR; Amin SB; Gu B; Chen TY; Lin YH; Chen J; Muller FL; Putluri N; Flores ER; DeMayo FJ; Baseler L; Rai K; Lee MG Cancer Cell; 2020 Apr; 37(4):599-617.e7. PubMed ID: 32243837 [TBL] [Abstract][Full Text] [Related]
5. Loss of Function of the Gene Encoding the Histone Methyltransferase KMT2D Leads to Deregulation of Mitochondrial Respiration. Pacelli C; Adipietro I; Malerba N; Squeo GM; Piccoli C; Amoresano A; Pinto G; Pucci P; Lee JE; Ge K; Capitanio N; Merla G Cells; 2020 Jul; 9(7):. PubMed ID: 32668765 [No Abstract] [Full Text] [Related]
6. Histone Methyltransferase KMT2D Regulates H3K4 Methylation and is Involved in the Pathogenesis of Ovarian Cancer. Li M; Shi M; Xu Y; Qiu J; Lv Q Cell Transplant; 2021; 30():9636897211027521. PubMed ID: 34705580 [TBL] [Abstract][Full Text] [Related]
10. Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3. Seehawer M; Li Z; Nishida J; Foidart P; Reiter AH; Rojas-Jimenez E; Goyette MA; Yan P; Raval S; Munoz Gomez M; Cejas P; Long HW; Papanastasiou M; Polyak K Nat Cell Biol; 2024 Jul; 26(7):1165-1175. PubMed ID: 38926506 [TBL] [Abstract][Full Text] [Related]
11. KMT2D-mediated H3K4me1 recruits YBX1 to facilitate triple-negative breast cancer progression through epigenetic activation of c-Myc. Yao B; Xing M; Zeng X; Zhang M; Zheng Q; Wang Z; Peng B; Qu S; Li L; Jin Y; Li H; Yuan H; Zhao Q; Ma C Clin Transl Med; 2024 Jul; 14(7):e1753. PubMed ID: 38967349 [TBL] [Abstract][Full Text] [Related]
12. COMPASS Ascending: Emerging clues regarding the roles of MLL3/KMT2C and MLL2/KMT2D proteins in cancer. Fagan RJ; Dingwall AK Cancer Lett; 2019 Aug; 458():56-65. PubMed ID: 31128216 [TBL] [Abstract][Full Text] [Related]
13. KMT2C and KMT2D aberrations in breast cancer. Tinsley E; Bredin P; Toomey S; Hennessy BT; Furney SJ Trends Cancer; 2024 Jun; 10(6):519-530. PubMed ID: 38453563 [TBL] [Abstract][Full Text] [Related]
14. KMT2D inhibits the growth and metastasis of bladder Cancer cells by maintaining the tumor suppressor genes. Sun P; Wu T; Sun X; Cui Z; Zhang H; Xia Q; Zhang D Biomed Pharmacother; 2019 Jul; 115():108924. PubMed ID: 31100540 [TBL] [Abstract][Full Text] [Related]
15. Methylation of the chromatin modifier KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancer. Blawski R; Vokshi BH; Guo X; Kittane S; Sallaku M; Chen W; Gjyzari M; Cheung T; Zhang Y; Simpkins C; Zhou W; Kulick A; Zhao P; Wei M; Shivashankar P; Prioleau T; Razavi P; Koche R; Rebecca VW; de Stanchina E; Castel P; Chan HM; Scaltriti M; Cocco E; Ji H; Luo M; Toska E Cell Rep; 2024 May; 43(5):114174. PubMed ID: 38700982 [TBL] [Abstract][Full Text] [Related]
16. H3K4me1 facilitates promoter-enhancer interactions and gene activation during embryonic stem cell differentiation. Kubo N; Chen PB; Hu R; Ye Z; Sasaki H; Ren B Mol Cell; 2024 May; 84(9):1742-1752.e5. PubMed ID: 38513661 [TBL] [Abstract][Full Text] [Related]
17. Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes. Wang J; Duan Z; Nugent Z; Zou JX; Borowsky AD; Zhang Y; Tepper CG; Li JJ; Fiehn O; Xu J; Kung HJ; Murphy LC; Chen HW Cancer Lett; 2016 Aug; 378(2):69-79. PubMed ID: 27164560 [TBL] [Abstract][Full Text] [Related]
18. KMT2D deficiency disturbs the proliferation and cell cycle activity of dental epithelial cell line (LS8) partially via Wnt signaling. Pang L; Tian H; Gao X; Wang W; Wang X; Zhang Z Biosci Rep; 2021 Nov; 41(11):. PubMed ID: 34724040 [TBL] [Abstract][Full Text] [Related]
19. Reprogramming of the Epigenome by MLL1 Links Early-Life Environmental Exposures to Prostate Cancer Risk. Wang Q; Trevino LS; Wong RL; Medvedovic M; Chen J; Ho SM; Shen J; Foulds CE; Coarfa C; O'Malley BW; Shilatifard A; Walker CL Mol Endocrinol; 2016 Aug; 30(8):856-71. PubMed ID: 27219490 [TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor 1 receptor activation promotes mammary gland tumor development by increasing glycolysis and promoting biomass production. Ter Braak B; Siezen CL; Lee JS; Rao P; Voorhoeve C; Ruppin E; van der Laan JW; van de Water B Breast Cancer Res; 2017 Feb; 19(1):14. PubMed ID: 28173837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]